Capitalization Matters. 3.3.1. Immediately prior to the Initial Closing and any Subsequent Closing, if and as applicable, the total authorized capital stock of the Company, consists of: (a) 100,000,000 shares of common stock; and (b) 10,000,000 shares of preferred stock, of which none are issued and outstanding.
Appears in 2 contracts
Samples: Securities Purchase Agreement (NXT-Id, Inc.), Securities Purchase Agreement (NXT-Id, Inc.)
Capitalization Matters. 3.3.1. Immediately prior to the Initial Closing and any Subsequent Closing, if and as applicable, the total authorized capital stock of the Company, consists of: (a) 100,000,000 shares of common stockCommon Stock, of which 19,363,539 shares are issued and outstanding; and (b) 10,000,000 5,000,000 shares of preferred stockPreferred Stock, of which none are issued and outstanding.
Appears in 2 contracts
Samples: Unit Purchase Agreement (Boston Therapeutics, Inc.), Unit Purchase Agreement (Boston Therapeutics, Inc.)
Capitalization Matters. 3.3.1. Immediately prior to the Initial Closing and any Subsequent Closing, if and as applicable, the total authorized capital stock of the Company, consists of: (a) 100,000,000 490,000,000 shares of common stock; and (b) 10,000,000 shares of preferred stock, of which none are issued and outstanding.
Appears in 1 contract
Samples: Securities Purchase Agreement (Black Cactus Global, Inc.)
Capitalization Matters. 3.3.1. Immediately prior to the Initial Closing and any Subsequent Closing, if and as applicable, the total authorized capital stock of the Company, consists of: (a) 100,000,000 200,000,000 shares of common stockCommon Stock, of which 66,263,600 are issued and outstanding as of the date of the Memorandum; and (b) 10,000,000 shares of preferred stockPreferred Stock, of which none are issued and outstanding.
Appears in 1 contract
Samples: Unit Purchase Agreement (Protea Biosciences Group, Inc.)
